Burkhart Schraven

Title: Burkhart Schraven: Innovator in Immunology

Introduction

Burkhart Schraven is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of immunology, particularly through his innovative research and patents. With a total of 2 patents, his work focuses on proteins that play a crucial role in treating diseases of the immune system.

Latest Patents

Schraven's latest patents include "Nucleic acid molecules encoding PP32: a newly identified CD45-associated protein." This invention relates to a newly identified protein that is useful for treating diseases of the immune system. It encompasses methods for obtaining the protein, isolated nucleic acids encoding the protein, and methods for obtaining inhibitors of the protein. The protein is characterized by an apparent molecular weight of about 32 kD, an isoelectric point of about 4.0-4.5, and coprecipitation with CD45. Additionally, this protein may be utilized in in vitro or in vivo assays to identify inhibitors of T cell activation.

Career Highlights

Throughout his career, Burkhart Schraven has worked with prominent companies such as BASF Aktiengesellschaft. His experience in these organizations has contributed to his expertise in the field of immunology and innovation.

Collaborations

Some of his notable coworkers include Stefan Meuer and David Schoenhaut. Their collaboration has likely fostered an environment of innovation and research excellence.

Conclusion

Burkhart Schraven's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in treating immune system diseases.